Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2014, Article ID 576373, 5 pages
http://dx.doi.org/10.1155/2014/576373
Case Report

Dynamics of Graft Function Measured by DNA-Technology in a Patient with Severe Aplastic Anemia and Repeated Stem Cell Transplantation

1Department of Pediatrics/Pediatric Hematology and Oncology Unit, Medical University Plovdiv, 15A Vasil Aprilov Boulevard, 4000 Plovdiv, Bulgaria
2Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical University Graz, Auenbruggerplatz 34/2, 8036 Graz, Austria

Received 28 November 2013; Accepted 27 January 2014; Published 4 March 2014

Academic Editor: Yasuhiko Sugawara

Copyright © 2014 Anna Karastaneva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. M. Camitta, E. D. Thomas, and D. G. Nathan, “Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality,” Blood, vol. 48, no. 1, pp. 63–70, 1976. View at Google Scholar · View at Scopus
  2. N. S. Young, P. Scheinberg, and R. T. Calado, “Aplastic anemia,” Current Opinion in Hematology, vol. 15, no. 3, pp. 162–168, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. E. P. Hochberg, D. B. Miklos, D. Neuberg et al., “A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation,” Blood, vol. 101, no. 1, pp. 363–369, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. Ş. Z. Aki, G. T. Sucak, Z. N. Özkurt, Z. A. Yeǧin, M. Yaǧci, and R. Haznedar, “Allogeneic stem cell transplantation for severe aplastic anemia: Graft rejection remains a problem,” Transfusion and Apheresis Science, vol. 40, no. 1, pp. 5–11, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Al-Qurashi, M. Ayas, F. Al Sharif et al., “Second allogeneic bone marrow transplantation after myeloablative conditioning analysis of 43 cases from single institution,” Hematology, vol. 9, no. 2, pp. 123–129, 2004. View at Google Scholar · View at Scopus
  6. I.-J. Chung, J.-J. Lee, M.-R. Park et al., “Allogeneic peripheral blood stem cell rescue of late graft failure after bone marrow transplantation in patients with aplastic anemia,” Journal of Korean medical science, vol. 17, no. 4, pp. 468–474, 2002. View at Google Scholar · View at Scopus
  7. A. Bacigalupo, F. Locatelli, E. Lanino et al., “Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: A report from the EBMT-SAA Working Party,” Bone Marrow Transplantation, vol. 36, no. 11, pp. 947–950, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. C. R. De Medeiros, M. A. Bitencourt, B. C. Medeiros, L. Ioshizumi, and R. Pasquini, “Second bone marrow transplantation for severe aplastic anemia: Analysis of 34 cases,” Bone Marrow Transplantation, vol. 28, no. 10, pp. 941–944, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Eapen, S. M. Davies, and N. K. C. Ramsay, “Late graff rejection and second infusion of bone marrow in children with aplastic anaemia,” British Journal of Haematology, vol. 104, no. 1, pp. 186–188, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Nemunaitis, J. W. Singer, C. D. Buckner et al., “Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation,” Blood, vol. 76, no. 1, pp. 245–253, 1990. View at Google Scholar · View at Scopus
  11. K. Kaptan, C. Beyan, A. U. Ural et al., “Successful treatment of severe aplastic anemia associated with Human parvovirus B19 and Epstein-Barr virus in a healthy subject with allo-BMT,” American Journal of Hematology, vol. 67, no. 4, pp. 252–255, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Lackner, P. Sovinz, M. Benesch et al., “The spectrum of parvovirus B19 infection in a pediatric hemato-oncologic ward,” Pediatric Infectious Disease Journal, vol. 30, no. 5, pp. 440–442, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Osaki, K. Matsubara, H. Nigami et al., “Severe aplastic anemia associated with human parvovirus B19 infection in a patient without underlying disease,” Annals of Hematology, vol. 78, no. 2, pp. 83–86, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Yetgin, M. Cetin, E. Ozyürek, D. Aslan, and D. Uçkan, “Parvovirus B19 infection associated with severe aplastic anemia in an immunocompetent patient,” Journal of Pediatric Hematology/Oncology, vol. 21, no. 3, pp. 223–226, 2004. View at Google Scholar
  15. K. E. Brown and N. S. Young, “Parvoviruses and bone marrow failure,” Stem Cells, vol. 14, no. 2, pp. 151–163, 1996. View at Google Scholar · View at Scopus
  16. E. D. Heegaard and K. E. Brown, “Human parvovirus B19,” Clinical Microbiology Reviews, vol. 15, no. 3, pp. 485–505, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. G. B. Segel and M. A. Lichtman, “Chapter 34: aplastic anemia: acquired and inherited,” in Williams Hematology, vol. 8, pp. 463–483, 2010. View at Google Scholar
  18. X. H. Qian, G. C. Zhang, X. Y. Jiao et al., “Aplastic anaemia associated with parvovirus B19 infection,” Archives of Disease in Childhood, vol. 87, no. 5, pp. 436–437, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Mishra, P. Malhotra, R. K. Ratho, M. P. Singh, S. Varma, and N. Varma, “Human parvovirus B19 in patients with aplastic anemia,” American Journal of Hematology, vol. 79, no. 2, pp. 166–167, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Urban, H. Lackner, E. Mller et al., “Stem cell transplantation in 6 children with parvovirus B19- induced severe aplastic anaemia or myelodysplastic syndrome,” Klinische Padiatrie, vol. 223, no. 6, pp. 332–334, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Sierra, M. J. Terol, A. Urbano-Ispizua et al., “Different response to recombinant human granulocyte-macrophage colony-stimulating factor in primary and secondary graft failure after bone marrow transplantation,” Experimental Hematology, vol. 22, no. 7, pp. 566–572, 1994. View at Google Scholar · View at Scopus
  22. D. J. Weisdorf, C. M. Verfaillie, S. M. Davies et al., “Hematopoietic growth factors for graft failure after bone marrow transplantation: a randomized trial of granulocyte-macrophage colony- stimulating factor (GM-CSF) versus sequential GM-CSF plus granulocyte-CSF,” Blood, vol. 85, no. 12, pp. 3452–3456, 1995. View at Google Scholar · View at Scopus
  23. P. Guardiola, M. Kuentz, F. Garban et al., “Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia,” British Journal of Haematology, vol. 111, no. 1, pp. 292–302, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. S. R. McCann, A. Bacigalupo, E. Gluckman et al., “Graft rejection and second bone marrow transplants for acquired aplastic anaemia: a report from the aplastic anaemia working party of the European bone marrow transplant group,” Bone Marrow Transplantation, vol. 13, no. 3, pp. 233–237, 1994. View at Google Scholar · View at Scopus
  25. E. D. Thomas, R. Storb, and E. R. Giblett, “Recovery from aplastic anemia following attempted marrow transplantation,” Experimental Hematology, vol. 4, no. 2, pp. 97–102, 1976. View at Google Scholar · View at Scopus